Find and Treat Coronary Artery Disease with Bayer’s Medrad-Possis Posse
Bayer Healthcare affiliate Medrad and Minneapolis, MN-based Possis Medical have entered into a definitive merger agreement whereby Medrad will acquire Possis for $19.50 a share, […]